466.80

1.32% 6.06

After Hours: 466.80

Medpace Holdings Inc (MEDP)

Overview News Price History Option Chain Financials Discussions Forecast

Medpace Holdings Inc stock is traded at $466.80, with a volume of 397.82K. It is up +1.32% in the last 24 hours and up +6.56% over the past month. Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Previous Close:

$460.74

Open:

$465.61

24h Volume:

397.82K

Relative Volume:

1.22

Market Cap:

$13.25B

Revenue:

$2.53B

Net Income/Loss:

$451.12M

P/E Ratio:

30.52

EPS:

15.2927

Net Cash Flow:

$681.87M

1W Performance:

+2.64%

1M Performance:

+6.56%

6M Performance:

-4.33%

1Y Performance:

+43.85%

1-Day Range:

$460.33

$471.91

1-Week Range:

$446.89

$471.91

52-Week Range:

$250.05

$628.92

Medpace Holdings Inc Stock (MEDP) Company Profile

Name

Medpace Holdings Inc

Sector

Healthcare (1114)

Industry

Diagnostics & Research (51)

Phone

(513) 579-9911

Address

5375 MEDPACE WAY, CINCINNATI, OH

Employee

6,200

Twitter

@WorkatMedpace

Next Earnings Date

2026-04-20

Latest SEC Filings

MEDP's Discussions on Twitter

Compare MEDP vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MEDP Medpace Holdings Inc	466.80	13.08B	2.53B	451.12M	681.87M	15.29
TMO Thermo Fisher Scientific Inc	490.77	182.14B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	187.15	134.43B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	575.72	45.40B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	112.98	32.27B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	302.32	29.62B	3.17B	642.63M	516.49M	10.77

Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-06-26	Upgrade	Barclays	Underweight → Equal Weight
Mar-03-26	Initiated	RBC Capital Mkts	Outperform
Feb-18-26	Upgrade	TD Cowen	Sell → Hold
Feb-13-26	Upgrade	Jefferies	Hold → Buy
Feb-10-26	Upgrade	Robert W. Baird	Neutral → Outperform
Nov-13-25	Initiated	BMO Capital Markets	Market Perform
Oct-02-25	Downgrade	Barclays	Equal Weight → Underweight
Sep-03-25	Downgrade	Rothschild & Co Redburn	Buy → Neutral
Jul-29-25	Downgrade	UBS	Neutral → Sell
Jul-23-25	Downgrade	TD Cowen	Hold → Sell
Jun-24-25	Initiated	Barclays	Equal Weight
Apr-22-25	Downgrade	William Blair	Outperform → Mkt Perform
Apr-14-25	Downgrade	TD Cowen	Buy → Hold
Mar-24-25	Initiated	Leerink Partners	Market Perform
Oct-23-24	Downgrade	Robert W. Baird	Outperform → Neutral
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-27-24	Downgrade	UBS	Buy → Neutral
Sep-25-24	Downgrade	Jefferies	Buy → Hold
Aug-01-24	Initiated	Truist	Hold
May-29-24	Initiated	TD Cowen	Buy
May-28-24	Initiated	Mizuho	Buy
Apr-23-24	Upgrade	Jefferies	Hold → Buy
Mar-18-24	Initiated	Deutsche Bank	Hold
Feb-15-24	Upgrade	UBS	Neutral → Buy
Oct-24-23	Upgrade	Robert W. Baird	Neutral → Outperform
May-08-23	Upgrade	Guggenheim	Neutral → Buy
Oct-27-22	Upgrade	UBS	Sell → Neutral
Sep-07-22	Initiated	UBS	Sell
May-24-22	Initiated	Guggenheim	Neutral
Aug-05-21	Resumed	Credit Suisse	Outperform
Oct-02-20	Upgrade	Truist	Hold → Buy
Jun-08-20	Upgrade	Robert W. Baird	Underperform → Neutral
May-13-20	Downgrade	Wolfe Research	Outperform → Peer Perform
Apr-30-20	Upgrade	SunTrust	Sell → Hold
Apr-20-20	Downgrade	Robert W. Baird	Neutral → Underperform
Mar-17-20	Downgrade	SunTrust	Hold → Sell
Jan-27-20	Downgrade	SunTrust	Buy → Hold
Oct-31-18	Upgrade	SunTrust	Hold → Buy
Sep-17-18	Initiated	SunTrust	Hold
Jul-31-18	Upgrade	William Blair	Mkt Perform → Outperform
Nov-01-17	Downgrade	William Blair	Outperform → Mkt Perform
Sep-29-17	Initiated	Raymond James	Mkt Perform
Jul-10-17	Downgrade	KeyBanc Capital Mkts	Overweight → Sector Weight

View All

Medpace Holdings Inc Stock (MEDP) Latest News

Mar 25, 2026

Why Medpace (MEDP) Outpaced the Stock Market Today - Yahoo Finance UK

Mar 25, 2026

Congress Asset Management Co. Has $33.91 Million Stake in Medpace Holdings, Inc. $MEDP - MarketBeat

Mar 25, 2026

Mar 24, 2026

Medpace Holdings Hits Day Low of $442.83 Amid Price Pressure - Markets Mojo

Mar 24, 2026

Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026 - Bluefield Daily Telegraph

Mar 24, 2026

Mar 23, 2026

Jefferies upgrades Medpace Holdings (MEDP) - MSN

Mar 23, 2026

Mar 22, 2026

Medpace Holdings Inc stock faces pressure amid clinical trial sector volatility - AD HOC NEWS

Mar 22, 2026

Mar 20, 2026

Strategic Sale: Jesse J Geiger Decides To Exercise Options Worth $10.24M At Medpace Holdings - Benzinga

Mar 20, 2026

Medpace Holdings, Inc. Experiences Revision in Stock Evaluation Amid Competitive Landscape - Markets Mojo

Mar 20, 2026

Decliners Report: Should value investors consider Medpace Holdings Inc2026 Analyst Calls & Accurate Entry and Exit Point Alerts - baoquankhu1.vn

Mar 20, 2026

Argent Capital Management LLC Sells 2,787 Shares of Medpace Holdings, Inc. $MEDP - MarketBeat

Mar 20, 2026

Mar 19, 2026

Medpace Holdings president sells $14.44M in stock By Investing.com - Investing.com South Africa

Mar 19, 2026

Medpace EVP exercises options for 12,000 shares | MEDP SEC FilingForm 4 - Stock Titan

Mar 19, 2026

Medpace (NASDAQ: MEDP) president exercises options, sells 31,707 shares - Stock Titan

Mar 19, 2026

Medpace Holdings Inc Stock (ISIN: US5840631062) Faces Mixed Analyst Signals Amid Strong CRO Demand - AD HOC NEWS

Mar 19, 2026

Does Medpace Holdings (MEDP) Have a Long Runway For Growth? - MSN

Mar 19, 2026

Mar 18, 2026